Reme-D: Funding, Investors & Team (Oct 2026)
Reme-D is a cutting-edge technology company that has patented technology, which is revolutionizing healthcare in areas with limited resources by providing cost-effective and efficient disease testing systems. This ensures that everyone has equal access to essential medical diagnostics.
Reme-D has raised $1.9M across 3 funding rounds on record, the most recent a Seed of $1.4M announced in Jul 2026.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Reme-D Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Reme-D Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Reme-D announced an undisclosed round in Jun 2024; the amount was not disclosed.
1.8 years later, a Seed of $500k was announced in Apr 2026.
3 months later, a Seed of $1.4M was announced in Jul 2026.
Reme-D Investors
9 investors are recorded in total; the 5 named above are those the record identifies.
Reme-D Founders and Leadership Team
Contact details for the Reme-D team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Reme-D Funding Compared to Other Biotechnology Startups
Reme-D's latest round of $1.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Reme-D in Biotechnology and New York
Companies Similar to Reme-D
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Reme-D Funding FAQs
What does Reme-D do?
Reme-D is a cutting-edge technology company that has patented technology, which is revolutionizing healthcare in areas with limited resources by providing cost-effective and efficient disease testing systems. This ensures that everyone has equal access to essential medical diagnostics.
How much funding has Reme-D raised?
Reme-D has raised $1.9M across 3 rounds on record. The most recent is a Seed of $1.4M announced in Jul 2026.
When did Reme-D last raise funding?
Reme-D's most recent funding round on record is a Seed of $1.4M, announced in Jul 2026.
Who has invested in Reme-D?
Investors on record for Reme-D include Anara Impact Capital, Wharton School of the University of Pennsylvania, Mohammed Bin Rashid Innovation Fund (MBRIF), A15, Global Innovation Fund. FundedIQ records 9 investors in total.
Who founded Reme-D?
FundedIQ lists Salma Tammam (Founder) at Reme-D.
Where is Reme-D headquartered?
Reme-D is based in New York, United States.
How many employees does Reme-D have?
Reme-D is in the 11-50 employee band.
When was Reme-D founded?
Reme-D was founded in 2022.
How does Reme-D's funding compare to other Biotechnology startups?
Reme-D's latest round of $1.4M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Reme-D Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Reme-D is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.